#AHA22
Virtual Experience Access
Sessions Posters
Late-Breaking Science
Daily Coverage
Industry Highlights
Featured Exhibitors
Program
Previews
AHA22
AHA/TCT alliance drives new programming
As part of an educational collaboration between Scientific Sessions and the Cardiovascular Research Foundation’s TCT Conference, #AHA22 is featuring TCT at AHA programming to advance research in CVD and interventional therapies.
AHA22
Early ablation bests medication in treatment naïve AFib patients
AHA22
First-in-class aminopeptidase-A inhibitor fails to reduce treatment-resistant hypertension
AHA22
#AHA 22 Closing Session: That’s a wrap
AHA22
Congratulations to the winners of the Wellness Challenge and Scavenger Hunt
AHA22
Special Recognition to the Hinsdale Humane Society
AHA22
Trial results shed light on tool for assessing VTE risk, routine anticoagulation for non-hospitalized COVID patients, and clinical outcomes of open vs. endovascular surgery for advanced PAD
Sponsored
Data-driven precision medicine
Finding and helping patients with undiagnosed or undertreated cardiovascular diseases
AHA22
Trials’ results highlight supplement ineffectiveness and potential for novel therapies to lower lipoprotein(a), reduce CKD progression
AHA22
Medtech is getting smarter — and so is patient care
Four new innovations seek to redefine how cardiovascular care is done.
AHA22
New digital hub offers professional education to complement lifelong learning
AHA22
Uncovering novel approaches in heart failure science
AHA22
Trial results report on benefits of radial artery for CABG, use of prophylactic methylprednisolone and ECMO for patients in cardiogenic shock
AHA22
Read all about it
Access top headlines from Scientific Sessions 2022.
AHA22
Science, medicine must be a ‘relentless force’ in fighting misinformation
The recent past can provide a light toward the future of public health and science education.
AHA22
Paul Dudley White International Lecture explores link between poverty, COVID-19 and CVD risk
Internationally acclaimed development economist will present perspectives on global cardiovascular risk reduction.
AHA22
The AHA selects seven Distinguished Scientists
AHA22
Trials’ results compare loop and thiazide diuretics and highlight ineffectiveness of novel fibrate therapy for reducing CV risk
AHA22
Moving past the status quo to overcome CVD and health disparities
AHA22
New therapies for cardiovascular disease reach clinical trial stage
AHA22
Transitioning from fellow to faculty can be tricky
AHA22
One Brave Idea aims to change the future of heart disease
AHA22
#AHA22 Symposia Schedule
AHA22
Stay connected
AHA22
Watch: Scientific Session Virtual Platform tour
AHA22
Paul Dudley White Lecture explores link between poverty, COVID-19 and CVD risk
AHA22
Industry Highlights channel provides added education
Get the Industry Highlights here
